Sartorius Stedim Biotech Virtual Annual Shareholders' Meeting on June 24, 2020
The health of its shareholders and employees has the highest priority for Sartorius Stedim Biotech. In view of the persistent coronavirus pandemic and to avoid any risk of infection, the Board of Directors has decided to hold this year’s annual general meeting by audiovisual conference, without the physical presence of shareholders or their proxies, pursuant to French Ordinance no. 2020-321 of March 25, 2020, which adapted the rules for holding shareholders’ meetings and conferences.
The annual general meeting will take place on June 24, 2020, at 10:00 a.m. (CEST) and be fully live-streamed on this website.
Holding the annual general meeting 2020 by audiovisual conference will require some modifications to the proceedings in comparison with previous years. We therefore request that the shareholders pay particular attention to the notes about registering for the meeting and about exercising their voting rights and other shareholder rights as described in the informative document about the holding of the General Meeting (pursuant to French Decree No. 2020-421 of April 10, 2020). Important information can also be found in the following press release.
Documents
1. Information to Shareholders
- 1.1 Notice of the meeting PDF | 937.6 KB
- 1.2 Shareholders' convening guide PDF | 3.8 MB
- 1.3 Vote form PDF | 1.7 MB
- 1.4 Request of documents by a shareholder PDF | 269.4 KB
- 1.5 Resolutions PDF | 920.9 KB
2. Documents to be presented to the Annual Combined General Meeting
- 2.1 Management Report of Sartorius Stedim Biotech S.A. PDF | 648.0 KB
- 2.2 Group Management Report PDF | 89.7 KB
- 2.3 Board of Director's Report on Corporate Governance PDF | 317.1 KB
- 2.4 Annual Financial Statements of Sartorius Stedim Biotech S.A. PDF | 158.5 KB
- 2.5 Consolidated financial statements of Sartorius Stedim Biotech Group PDF | 418.5 KB
- 2.6 Statutory auditors' report on the annual financial statement of Sartorius Stedim Biotech S.A. for the financial year closed 31.12.2019 PDF | 55.2 KB
- 2.7 Statutory auditors' report on the consolidated statements of Sartorius Stedim Biotech Group for the financial year closed 31.12.2019 PDF | 60.7 KB
- 2.8 Statutory auditors' report on the information disclosed in accordance with article L. 225-38 of the French Commercial Code PDF | 521.3 KB
- 2.9 Information regarding the Board of Directors’ members PDF | 161.8 KB
- 2.10 Delegations granted to the Board of Directors by the Shareholders’ Meeting PDF | 43.8 KB
- 2.11 Total number of shares and voting rights making up the issued capital PDF | 118.9 KB